Ventricular remodeling in heart failure: a credible surrogate endpoint

J Card Fail. 2003 Oct;9(5):350-3. doi: 10.1054/j.cardfail.2003.09.001.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Biomarkers
  • Endothelin Receptor Antagonists
  • Fibrinolytic Agents / therapeutic use
  • Heart Failure / drug therapy
  • Heart Failure / etiology
  • Heart Failure / physiopathology*
  • Humans
  • Myocardial Infarction / complications
  • Ventricular Remodeling* / drug effects

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Biomarkers
  • Endothelin Receptor Antagonists
  • Fibrinolytic Agents